Literature DB >> 10881471

Colorectal cancer: update on recent advances and their impact on screening protocols.

E N Briskey1, R J Pamies.   

Abstract

As the third leading cause of cancer cases and deaths in the United States, colorectal cancer has been an area of intense interest. The objectives of this article are, through a review of the literature published between 1995 to 1998, to examine current trends in the epidemiology of colorectal cancer, new information on genetic, dietary, and other risk factors; to evaluate the effectiveness of current screening guidelines for various populations; to review information on chemoprevention; and finally to examine new concepts on the horizon in the area of colorectal cancer research. Much of the recent research in the field has focused on etiology, dietary, and other risk factors. Many genetic factors have been discovered, which serve to elucidate the mechanism of pathogenesis of colorectal cancer as well as offer possible targets for treatment strategies. Dietary and risk factors for colorectal cancer may pave the way for chemoprevention. In light of the most recent information on colorectal cancer, one is able to more accurately assess current screening guidelines for their effectiveness in all populations based on epidemiologic data, as well as evaluate more novel screening strategies for their possible utility in the future. In addition to a review of the most up-to-date literature, the authors also provide their recommendations for screening based on the evidence in which the review of the literature provides. Finally, current and future treatment options are discussed. It is our hope that the physicians will find this review useful in the evaluation and care of patients at risk of developing colorectal cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10881471      PMCID: PMC2640566     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  45 in total

Review 1.  Risk factors for the development of colorectal carcinoma and their modification.

Authors:  J A Kroser; D R Bachwich; G R Lichtenstein
Journal:  Hematol Oncol Clin North Am       Date:  1997-08       Impact factor: 3.722

2.  The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.

Authors:  S Yokoyama; C H Shatney; H Mochizuki; K Hase; D L Johnson; S Cummings; M L Trollope; S Tamakuma
Journal:  Am Surg       Date:  1997-03       Impact factor: 0.688

Review 3.  Endoscopic screening for colorectal cancer.

Authors:  D Lieberman
Journal:  Gastroenterol Clin North Am       Date:  1997-03       Impact factor: 3.806

4.  Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67.

Authors:  L Qiao; S J Shiff; B Rigas
Journal:  Cancer Lett       Date:  1997-05-19       Impact factor: 8.679

5.  Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.

Authors:  B Levin; K Hess; C Johnson
Journal:  Arch Intern Med       Date:  1997-05-12

Review 6.  Tocopherols and the etiology of colon cancer.

Authors:  W L Stone; A M Papas
Journal:  J Natl Cancer Inst       Date:  1997-07-16       Impact factor: 13.506

7.  American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer.

Authors:  T Byers; B Levin; D Rothenberger; G D Dodd; R A Smith
Journal:  CA Cancer J Clin       Date:  1997 May-Jun       Impact factor: 508.702

Review 8.  Colorectal cancer. Clinical and pathologic features.

Authors:  R M Gore
Journal:  Radiol Clin North Am       Date:  1997-03       Impact factor: 2.303

Review 9.  Colorectal cancer. Screening strategies.

Authors:  D W Gelfand
Journal:  Radiol Clin North Am       Date:  1997-03       Impact factor: 2.303

Review 10.  Treatment of colorectal cancer. Current guidelines and future prospects for drug therapy.

Authors:  R Labianca; M A Pessi; G Zamparelli
Journal:  Drugs       Date:  1997-04       Impact factor: 11.431

View more
  2 in total

1.  Bacterial enterotoxins are associated with resistance to colon cancer.

Authors:  G M Pitari; L V Zingman; D M Hodgson; A E Alekseev; S Kazerounian; M Bienengraeber; G Hajnóczky; A Terzic; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

2.  Nested case-control study on the risk factors of colorectal cancer.

Authors:  Kun Chen; Jian Cai; Xi-Yong Liu; Xi-Yuan Ma; Kai-Yan Yao; Shu Zheng
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.